Article Text

Download PDFPDF
Treating pain related to Ehlers-Danlos syndrome with medical cannabis
  1. Sabeera Dar
  1. University College London Medical School, London, UK
  1. Correspondence to Dr Sabeera Dar; zchaarx{at}ucl.ac.uk

Abstract

We present the case of an 18-year-old woman who suffered from complications of Ehlers-Danlos syndrome (EDS). Her pain was poorly controlled despite being on a myriad of analgesic medications at the time. On initiating cannabinoid-based treatment, her pain was drastically reduced, immediately enhancing the patient’s quality of life. As the patient continued to self-administer, she was able to eliminate her opioid requirement. Considering the recent legalisation, we underline the need for physicians to be educated regarding the use of cannabinoids. In this case, specifically for chronic pain stemming from hypermobile EDS. Furthermore, we review the various impediments preventing ease of access to this potentially beneficial treatment.

  • health economics
  • connective tissue disease
  • musculoskeletal syndromes
  • physiotherapy (rehabilitation)
  • disability

Statistics from Altmetric.com

Footnotes

  • Twitter @sabeera_dar

  • Contributors SD is responsible for the conception and analysis of data. SD is grateful for the contributions of Patient-Led Engagement for Access for helping in the acquisition of data and reviewing drafts of the original manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer-reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.